Non-invasive, movement-based models were used to investigate muscle pain. In rats, the masseter muscle was rapidly stretched or electrically stimulated during forced lengthening to produce eccentric muscle contractions (EC). Both EC and stretching disrupted scattered myofibers and produced intramuscular plasma extravasation. Pro-inflammatory cytokines (IL-1b, TNF-a, IL-6) and vascular endothelial growth factor (VEGF) were elevated in the masseter 24 h following EC. At 48 h, neutrophils increased and ED1 macrophages infiltrated myofibers while ED2 macrophages were abundant at 4d. Mechanical hyperalgesia was evident in the ipsilateral head 4 h-4d after a single bout of EC and for 7d following multiple bouts (1 bout/d for 4d). Calcitonin gene-related peptide (CGRP) mRNA increased in the trigeminal ganglion 24 h following EC while immunoreactive CGRP decreased. By 2d, CGRP-muscle afferent numbers equaled naive numbers implying that CGRP is released following EC and replenished within 2d. EC elevated P2X 3 mRNA and increased P2X 3 muscle afferent neuron number for 12d while electrical stimulation without muscle contraction altered neither CGRP nor P2X 3 mRNA levels. Muscle stretching produced hyperalgesia for 2d whereas contraction alone produced no hyperalgesia. Stretching increased CGRP mRNA at 24 h but not CGRP-muscle afferent number at 2-12d. In contrast, stretching significantly increased the number of P2X 3 muscle afferent neurons for 12d. The sustained, elevated P2X 3 expression evoked by EC and stretching may enhance nociceptor responsiveness to ATP released during subsequent myofiber damage. Movement-based actions such as EC and muscle stretching produce unique tissue responses and modulate neuropeptide and nociceptive receptor expression in a manner particularly relevant to repeated muscle damage. Ó
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Introduction
Musculoskeletal pain is one of the most frequent symptoms encountered by primary care providers [48, 57] . In spite of this prevalence, the mechanisms involved in deep tissue pain are poorly understood and current therapies are not only ineffective but can also be dangerous [21, 37, 69] . Musculoskeletal disorders in the craniofacial region include temporomandibular disorders which frequently involve pain in the muscles of mastication [18, 62] . Fibromyalgia, a musculoskeletal disorder characterized by widespread muscle pain, also frequently involves pain in craniofacial muscles [40,76,77].
There are no widely accepted models of muscle pain in part because previous models are invasive and do not reproduce the characteristics of muscle pain. A common experimental method used to study muscle pain is to inject complete Freund's adjuvant (CFA) into muscle [3, 5, 6, 8, 16, 39, 86] . Other exogenous substances (hypertonic saline, mustard oil, carrageenan, capsaicin) and endogenous (serotonin, bradykinin, ATP, TNF-a, NGF) substances have also been used to model muscle pain [26, 29, 42, 49, 63, 78, 87, 88, 94, 98] . While these methods may provide insight into certain aspects of muscle pain such as pain produced by infection, poisoning and autoimmune dysfunction they do not incorporate movement or contractility, fundamental properties of muscle. For this reason we employed in vivo muscle contraction and rapid muscle stretching to study muscle nociceptive mechanisms.
Considerable evidence implicates the neuropeptide calcitonin gene-related peptide (CGRP) in deep tissue nociceptive mechanisms [14, 80] . Recently there has been a resurgence of interest in the role of neuropeptides in pain, in part due to the development of neuropep-
